|Articles|February 25, 2010

Pittsburgh Conference Achievement Award

The 2010 Pittsburgh Conference Achievement Award will be presented to Joshua J. Coon, Assistant Professor of Chemistry and Biomolecular Chemistry at the University of Wisconsin-Madison (Madison, Wisconsin), on Monday morning at Pittcon 2010. The award is sponsored jointly by the Pittsburgh Conference and the Society for Analytical Chemists of Pittsburgh (SACP).

Monday, March 1, 2010

8:00 a.m. Room 300

The 2010 Pittsburgh Conference Achievement Award will be presented to Joshua J. Coon, Assistant Professor of Chemistry and Biomolecular Chemistry at the University of Wisconsin-Madison (Madison, Wisconsin), on Monday morning at Pittcon 2010. The award is sponsored jointly by the Pittsburgh Conference and the Society for Analytical Chemists of Pittsburgh (SACP). The award will be presented to Coon by Gregg Gould, Chairman of SACP. The award recognizes scientists who have made outstanding achievements within 10 years of the completion of their Ph.D. research. Coon will receive the award for his work in developing and applying new mass spectrometry–based proteomic technologies. The award presentation will be followed by a session of oral presentations on the development and application of novel technologies for large-scale protein sequence analysis.,/p>

Coon’s research group uses cutting-edge mass spectrometry approaches to study molecular events that cause human embryonic stemcells to exit the pluripotent state. The group determines which signaling pathways are active in the cells and which proteins or protein networks are phosphorylated upon differentiation. The new mass spectrometry technologies are focused on interpreting the epigenetic codes and monitoring how the messages change during cell differentiation.

Coon came to the University of Wisconsin-Madison in 2005. He holds patents on various mass spectrometry technologies and has authored more than 40 peer-reviewed scientific publications. He has received various awards, including the Beckman Young Investigator Award, the American Society for Mass Spectrometry Research Award, the NSF Career Award, the Eli Lilly and Co. Young Investigator Award, and the Ken Standing Award.

Related to this article

Brandon E. Boor is the Dr. Margery E. Hoffman Associate Professor in the Lyles School of Civil and Construction Engineering at Purdue University. | Photo Credit: © Brandon Boor.
In the second part of our interview with Brandon Boor of Purdue University, he discusses how his team controls experimental variables during cleaning experiments in order to obtain interpretable data.
Scientist With Portable Spectrometer in Natural Field Setting ©  By Tika -chronicles-stock.adobe.com
The bulky bench-top NIR spectrometer is quietly being dismantled and rebuilt as a wafer-scale photonic chip, a self-calibrating algorithm, and a sensor small enough to ride in a shirt pocket. What once demanded a grating, a moving mirror, and a climate-controlled lab now fits inside a handheld module, a bioreactor probe, or a drone payload, and it increasingly figures out what it is looking at on its own.
Sizing Up the Nanoscale: Measuring Nanocluster Aerosol in Indoor Air
In the first part of a multi-part Q&A, Brandon Boor, the Dr. Margery E. Hoffman Associate Professor in the Lyles School of Civil and Construction Engineering at Purdue University, describes the instrumentation and methodology behind measuring nanoparticle size distributions at the nanocluster scale (1–3 nm) and outlines the technical challenges of acquiring reliable, real-time data at these dimensions.
Human body wireframe on glowing platform undergoing futuristic body scan. © sergray(noAIelemens) -chronicles-stock.adobe.com
Jurgen Popp, Thomas Mayerhofer, and colleagues at Leibniz IPHT and Friedrich Schiller University Jena introduce the Personalized Optical Digital Twin (PODT), a Photonics21 contribution to Europe's Virtual Human Twin ecosystem that connects molecular photonics—Raman blood analysis, coherent Raman tissue imaging, and multimodal endomicroscopy—with longitudinal physiology and clinical data. Drawing on the published multicenter INTELLIGENCE trials, the authors argue that technical feasibility and clinical utility must be evaluated separately as the field moves toward Europe's FP10 research agenda.